Daniel J. Skiest

7.7k citations
100 papers · 3.9k · 1 hit paper · h-index 35

Impact in

  • Virology top 0.5%
    • HIV Research and Treatment
    • HIV/AIDS Research and Interventions
    • HIV/AIDS drug development and treatment
    • Antimicrobial Resistance in Staphylococcus
    • Antifungal resistance and susceptibility

Papers in

    • Pneumocystis jirovecii pneumonia detection and treatment 16
    • Cytomegalovirus and herpesvirus research 11
    • Pneumonia and Respiratory Infections 7
    • HIV/AIDS Research and Interventions 26
    • HIV/AIDS drug development and treatment 19
    • Antimicrobial Resistance in Staphylococcus 7

Daniel J. Skiest

97 papers receiving 3.7k citations

Daniel J. Skiest's Hit Papers

Efavirenz plus Zidovudine and Lamivudine, Efavirenz plus Indinavir, and Indinavir plus Zidovudine and Lamivudine in the Treatment of HIV-1 Infection in Adults 1999 · 788 citations
7880+9+18Years since publication250500750

Peers

Daniel J. Skiest
Comparison fields: 5 of 130
  • Virology 1.2k
  • Infectious Diseases 2.5k
  • Emergency Medicine 563
  • Epidemiology 1.6k
  • Clinical Biochemistry 234
Replace Josep Mallolas with:
Josep Mallolas Spain
Elisa de Lazzari Spain
Lionel Piroth France
Giuliano Rizzardini Italy
Vincent Le Moing France
Cristina Mussini Italy
Christian Perronne France
Harry Lampiris United States
Sven A. Danner Netherlands
Esteban Ribera Spain
Daniel J. Skiest relative to Josep Mallolas Spain Josep Mallolas's profile →
Citations per field
00.5×1.5×1.9×
Josep Mallolas · 1×
Citations per year

Countries citing papers authored by Daniel J. Skiest

Since Specialization
Citations

This map shows the geographic impact of Daniel J. Skiest's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel J. Skiest with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel J. Skiest more than expected).

Fields of papers citing papers by Daniel J. Skiest

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel J. Skiest. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel J. Skiest. The network helps show where Daniel J. Skiest may publish in the future.

Co-authors

The 25 scholars most cited alongside Daniel J. Skiest, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Daniel J. Skiest Line = papers co-authored together Daniel J. Skiest links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 100 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Efavirenz plus Zidovudine and Lamivudine, Efavirenz plus Indinavir, and Indinavir plus Zidovudine and Lamivudine in the Treatment of HIV-1 Infection in Adults
Hit paper breakdown →
1999788
2 2010167
3 2006143
4 2006128
5 2002121
6 1996116
7 2007111
8 2006100
9 200089
10 200487
11 200785
12 200381
13 200376
14 200573
15 199770
16 201867
17 200966
18 200756
19 200056
20 200055

About Daniel J. Skiest

Daniel J. Skiest is a scholar working on Epidemiology, Infectious Diseases, Virology, Pharmacology and Public Health, Environmental and Occupational Health, having authored 100 papers that have together received 3.9k indexed citations. Recurring topics across this work include HIV Research and Treatment (27 papers), HIV/AIDS Research and Interventions (26 papers), HIV/AIDS drug development and treatment (19 papers), Pneumocystis jirovecii pneumonia detection and treatment (16 papers), Cytomegalovirus and herpesvirus research (11 papers), HIV-related health complications and treatments (7 papers), Pneumonia and Respiratory Infections (7 papers) and Antimicrobial Resistance in Staphylococcus (7 papers). The work is most often cited by research in Virology (1.2k citations), Infectious Diseases (2.5k citations), Emergency Medicine (563 citations), Epidemiology (1.6k citations) and Clinical Biochemistry (234 citations). Daniel J. Skiest has collaborated with scholars based in United States, Germany and Canada. Frequent co-authors include Karen T. Tashima, Nancy Ruíz, Anita Rachlis, Richard Stryker, Schlomo Staszewski, James Stanford, Philip Keiser, Javier O Morales-Ramirez, Douglas J. Manion and Dominic Labriola. Their work appears in journals such as Clinical Infectious Diseases, JAIDS Journal of Acquired Immune Deficiency Syndromes, International Journal of STD & AIDS, Journal of Infection and The Journal of Infectious Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact